Literature DB >> 15996329

[Clinicopathologic study of 24 patients with vulvar intraepithelial neoplasia III].

Hua Li1, Wen-hua Zhang, Ling-ying Wu, Rong Znang, Ping Bai.   

Abstract

OBJECTIVE: To review the diagnosis methods and treatment modalities of vulvar intraepithelial neoplasia III (VINIII) and to analyse its prognostic factors.
METHODS: The data of 24 patients with VINIII from 1992 to 2002 were retrospectively reviewed and analysed.
RESULTS: Among these 24 patients, 62.5% (15 patients) were aged less than 40 years and 37.5% (9 patients) over 40 years. Human papillomavirus (HPV) infection was found in 53.3% and 2/9 of these two groups. Treatment modality for all patients was surgical excision including extended local excision (33.3%) and simple vulvectomy (66.7%). 3 patients (12.5%) developed recurrence. Positive resection margin was correlated with recurrence, while age, HPV infection, multifocality and resection modality were not.
CONCLUSION: During recent years, the incidence of VIN has been on the increase in younger woman patients which maybe due to the increase of HPV infection, and the data show that the recurrence rate is correlated with positive margin. Treatment should be individualized and either extended local excision or simple vulvectomy is appropriate. Periodical follow-up should be done.

Entities:  

Mesh:

Year:  2005        PMID: 15996329

Source DB:  PubMed          Journal:  Zhonghua Zhong Liu Za Zhi        ISSN: 0253-3766


  2 in total

Review 1.  Medical and surgical interventions for the treatment of usual-type vulval intraepithelial neoplasia.

Authors:  Theresa A Lawrie; Andy Nordin; Manas Chakrabarti; Andrew Bryant; Sonali Kaushik; Litha Pepas
Journal:  Cochrane Database Syst Rev       Date:  2016-01-05

2.  Human papillomavirus genotyping and e6/e7 mRNA expression in greek women with intraepithelial neoplasia and squamous cell carcinoma of the vagina and vulva.

Authors:  Elpida Tsimplaki; Elena Argyri; Lina Michala; Maria Kouvousi; Aikaterini Apostolaki; George Magiakos; Issidora Papassideri; Efstathia Panotopoulou
Journal:  J Oncol       Date:  2011-12-05       Impact factor: 4.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.